Bartlett & Co’s Ingevity NGVT Stock Holding History

Bartlett & Co’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-287	Closed	-$10K	–	718
2016 Q2	$10K	Buy	+287	New	+$8.96K	﹤0.01%	611

Other funds holding NGVT

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

SAM

Silvercrest Asset Management New York $13.8B AUM 28.39% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Ruffer LLP London, United Kingdom $2.44B AUM 44.75% 1-Year Est. Return

Bartlett & Co's NGVT Position: Q3 2016 in Review

Bartlett & Co sold out of Ingevity (NGVT) in Q3 2016, closing a stake of 287 shares — an estimated $10K sold.

Bartlett & Co first reported a position in NGVT in Q2 2016 and held it in 1 quarter. The position peaked at $10K in Q2 2016. 257 funds tracked by Wall St. Rank hold NGVT as of Q3 2016.

Bartlett & Co reported no remaining Ingevity position as of Q3 2016 after selling out during the quarter.
Bartlett & Co sold 287 Ingevity shares in Q3 2016, an estimated $10K.
Bartlett & Co first reported a position in Ingevity in Q2 2016 and held it in 1 quarter.
Bartlett & Co's Ingevity position peaked at $10K in Q2 2016.
257 funds tracked by Wall St. Rank held Ingevity as of Q3 2016.

Based on Bartlett & Co's 13F filing for Q3 2016, filed 24 Oct 2016.